Essex Woodlands Management, Inc. - Q4 2015 holdings

$547 Million is the total value of Essex Woodlands Management, Inc.'s 9 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 0.0% .

 Value Shares↓ Weighting
ABMD  ABIOMED INC$194,102,000
-2.7%
2,150,0000.0%35.50%
-2.6%
RVNC  REVANCE THERAPEUTICS INC$156,864,000
+14.8%
4,592,0470.0%28.69%
+14.8%
CORI  CORIUM INTL INC$75,949,000
-13.2%
9,353,3040.0%13.89%
-13.1%
ENTL  ENTELLUS MED INC$64,291,000
-6.4%
3,813,1970.0%11.76%
-6.4%
AXGN  AXOGEN INC$24,306,000
+21.4%
4,861,1110.0%4.44%
+21.4%
ELGX  ENDOLOGIX INC$18,480,000
-12.9%
1,257,4680.0%3.38%
-12.9%
ACUR  ACURA PHARMACEUTICALS INC$4,891,000
+6.4%
1,956,3970.0%0.89%
+6.3%
MNOV  MEDICINOVA INC$4,155,000
+26.3%
1,170,3700.0%0.76%
+26.5%
CBIO  CATALYST BIOSCIENCES INC$3,779,000
-33.2%
1,179,3520.0%0.69%
-33.2%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-02-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MEDICINOVA INC45Q2 20246.5%
REVANCE THERAPEUTICS INC42Q2 202444.6%
AXOGEN INC26Q4 202143.3%
ENDOLOGIX INC24Q1 201922.5%
ABIOMED INC20Q1 201852.1%
CORIUM INTL INC20Q1 201923.5%
TELA BIO, INC.19Q2 202431.5%
VENUS CONCEPT, INC.17Q4 202321.3%
EYEPOINT PHARMACEUTICALS INC15Q2 202427.6%
ACURA PHARMACEUTICALS INC15Q1 20191.4%

View Essex Woodlands Management, Inc.'s complete holdings history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15

View Essex Woodlands Management, Inc.'s complete filings history.

Compare quarters

Export Essex Woodlands Management, Inc.'s holdings